Skip to main content
PMC home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1993 Aug 1;122(3):685–701. doi: 10.1083/jcb.122.3.685

Osteoblasts are target cells for transformation in c-fos transgenic mice

PMCID: PMC2119671  PMID: 8335693

Abstract

We have generated transgenic mice expressing the proto-oncogene c-fos from an H-2Kb class I MHC promoter as a tool to identify and isolate cell populations which are sensitive to altered levels of Fos protein. All homozygous H2-c-fosLTR mice develop osteosarcomas with a short latency period. This phenotype is specific for c-fos as transgenic mice expressing the fos- and jun-related genes, fosB and c-jun, from the same regulatory elements do not develop any pathology despite high expression in bone tissues. The c-fos transgene is not expressed during embryogenesis but is expressed after birth in bone tissues before the onset of tumor formation, specifically in putative preosteoblasts, bone- forming osteoblasts, osteocytes, as well as in osteoblastic cells present within the tumors. Primary and clonal cell lines established from c-fos-induced tumors expressed high levels of exogenous c-fos as well as the bone cell marker genes, type I collagen, alkaline phosphatase, and osteopontin/2ar. In contrast, osteocalcin/BGP expression was either low or absent. All cell lines were tumorigenic in vivo, some of which gave rise to osteosarcomas, expressing exogenous c- fos mRNA, and Fos protein in osteoblastic cells. Detailed analysis of one osteogenic cell line, P1, and several P1-derived clonal cell lines indicated that bone-forming osteoblastic cells were transformed by Fos. The regulation of osteocalcin/BGP and alkaline phosphatase gene expression by 1,25-dihydroxyvitamin D3 was abrogated in P1-derived clonal cells, whereas glucocorticoid responsiveness was unaltered. These results suggest that high levels of Fos perturb the normal growth control of osteoblastic cells and exert specific effects on the expression of the osteoblast phenotype.

Full Text

The Full Text of this article is available as a PDF (8.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. M., Cory S. Transgenic models of tumor development. Science. 1991 Nov 22;254(5035):1161–1167. doi: 10.1126/science.1957168. [DOI] [PubMed] [Google Scholar]
  2. Aguzzi A., Wagner E. F., Williams R. L., Courtneidge S. A. Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol. 1990 Jun;2(6):533–543. [PubMed] [Google Scholar]
  3. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  4. Aronow M. A., Gerstenfeld L. C., Owen T. A., Tassinari M. S., Stein G. S., Lian J. B. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol. 1990 May;143(2):213–221. doi: 10.1002/jcp.1041430203. [DOI] [PubMed] [Google Scholar]
  5. Baichwal V. R., Park A., Tjian R. v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor. Nature. 1991 Jul 11;352(6331):165–168. doi: 10.1038/352165a0. [DOI] [PubMed] [Google Scholar]
  6. Bellows C. G., Aubin J. E., Heersche J. N., Antosz M. E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int. 1986 Mar;38(3):143–154. doi: 10.1007/BF02556874. [DOI] [PubMed] [Google Scholar]
  7. Bellows C. G., Aubin J. E., Heersche J. N. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology. 1987 Dec;121(6):1985–1992. doi: 10.1210/endo-121-6-1985. [DOI] [PubMed] [Google Scholar]
  8. Birek C., Huang H. Z., Birek P., Tenenbaum H. C. c-fos oncogene expression in dexamethasone stimulated osteogenic cells in chick embryo periosteal cultures. Bone Miner. 1991 Dec;15(3):193–207. doi: 10.1016/0169-6009(91)90125-j. [DOI] [PubMed] [Google Scholar]
  9. Braselmann S., Bergers G., Wrighton C., Graninger P., Superti-Furga G., Busslinger M. Identification of Fos target genes by the use of selective induction systems. J Cell Sci Suppl. 1992;16:97–109. doi: 10.1242/jcs.1992.supplement_16.12. [DOI] [PubMed] [Google Scholar]
  10. Caubet J. F., Bernaudin J. F. Expression of the c-fos proto-oncogene in bone, cartilage and tooth forming tissues during mouse development. Biol Cell. 1988;64(1):101–104. doi: 10.1016/0248-4900(88)90100-1. [DOI] [PubMed] [Google Scholar]
  11. Caubet J. F. c-fos proto-oncogene expression in the nervous system during mouse development. Mol Cell Biol. 1989 May;9(5):2269–2272. doi: 10.1128/mcb.9.5.2269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 1988 Aug 12;54(4):541–552. doi: 10.1016/0092-8674(88)90076-1. [DOI] [PubMed] [Google Scholar]
  13. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  14. Closs E. I., Murray A. B., Schmidt J., Schön A., Erfle V., Strauss P. G. c-fos expression precedes osteogenic differentiation of cartilage cells in vitro. J Cell Biol. 1990 Sep;111(3):1313–1323. doi: 10.1083/jcb.111.3.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cohen D. R., Vandermark S. E., McGovern J. D., Bradley M. P. Transcriptional regulation in the testis: a role for transcription factor AP-1 complexes at various stages of spermatogenesis. Oncogene. 1993 Feb;8(2):443–455. [PubMed] [Google Scholar]
  16. Craig A. M., Denhardt D. T. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene. 1991 Apr;100:163–171. doi: 10.1016/0378-1119(91)90362-f. [DOI] [PubMed] [Google Scholar]
  17. Craig A. M., Smith J. H., Denhardt D. T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem. 1989 Jun 5;264(16):9682–9689. [PubMed] [Google Scholar]
  18. De Togni P., Niman H., Raymond V., Sawchenko P., Verma I. M. Detection of fos protein during osteogenesis by monoclonal antibodies. Mol Cell Biol. 1988 May;8(5):2251–2256. doi: 10.1128/mcb.8.5.2251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Diamond M. I., Miner J. N., Yoshinaga S. K., Yamamoto K. R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 1990 Sep 14;249(4974):1266–1272. doi: 10.1126/science.2119054. [DOI] [PubMed] [Google Scholar]
  20. Distel R. J., Ro H. S., Rosen B. S., Groves D. L., Spiegelman B. M. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos. Cell. 1987 Jun 19;49(6):835–844. doi: 10.1016/0092-8674(87)90621-0. [DOI] [PubMed] [Google Scholar]
  21. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Jr, Butel J. S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992 Mar 19;356(6366):215–221. doi: 10.1038/356215a0. [DOI] [PubMed] [Google Scholar]
  22. Dony C., Gruss P. Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature. 1987 Aug 20;328(6132):711–714. doi: 10.1038/328711a0. [DOI] [PubMed] [Google Scholar]
  23. Field S. J., Johnson R. S., Mortensen R. M., Papaioannou V. E., Spiegelman B. M., Greenberg M. E. Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9306–9310. doi: 10.1073/pnas.89.19.9306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Finkel M. P., Biskis B. O., Jinkins P. B. Virus induction of osteosarcomas in mice. Science. 1966 Feb 11;151(3711):698–701. doi: 10.1126/science.151.3711.698. [DOI] [PubMed] [Google Scholar]
  25. Fournier B., Price P. A. Characterization of a new human osteosarcoma cell line OHS-4. J Cell Biol. 1991 Aug;114(3):577–583. doi: 10.1083/jcb.114.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Goralczyk R., Closs E. I., Rüther U., Wagner E. F., Strauss P. G., Erfle V., Schmidt J. Characterization of fos-induced osteogenic tumours and tumour-derived murine cell lines. Differentiation. 1990 Aug;44(2):122–131. doi: 10.1111/j.1432-0436.1990.tb00545.x. [DOI] [PubMed] [Google Scholar]
  27. Guenther H. L., Hofstetter W., Stutzer A., Mühlbauer R., Fleisch H. Evidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium. Endocrinology. 1989 Oct;125(4):2092–2102. doi: 10.1210/endo-125-4-2092. [DOI] [PubMed] [Google Scholar]
  28. Hanahan D. Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet. 1988;22:479–519. doi: 10.1146/annurev.ge.22.120188.002403. [DOI] [PubMed] [Google Scholar]
  29. Heath J. K., Rodan S. B., Yoon K., Rodan G. A. Rat calvarial cell lines immortalized with SV-40 large T antigen: constitutive and retinoic acid-inducible expression of osteoblastic features. Endocrinology. 1989 Jun;124(6):3060–3068. doi: 10.1210/endo-124-6-3060. [DOI] [PubMed] [Google Scholar]
  30. Johnson R. S., Spiegelman B. M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 1992 Nov 13;71(4):577–586. doi: 10.1016/0092-8674(92)90592-z. [DOI] [PubMed] [Google Scholar]
  31. Kasik J. W., Wan Y. J., Ozato K. A burst of c-fos gene expression in the mouse occurs at birth. Mol Cell Biol. 1987 Sep;7(9):3349–3352. doi: 10.1128/mcb.7.9.3349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kellermann O., Buc-Caron M. H., Marie P. J., Lamblin D., Jacob F. An immortalized osteogenic cell line derived from mouse teratocarcinoma is able to mineralize in vivo and in vitro. J Cell Biol. 1990 Jan;110(1):123–132. doi: 10.1083/jcb.110.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kelloff G. J., Lane W. T., Turner H. C., Huebner R. J. In vivo studies of the FBJ murine osteosarcoma virus. Nature. 1969 Sep 27;223(5213):1379–1380. doi: 10.1038/2231379a0. [DOI] [PubMed] [Google Scholar]
  34. Kerr L. D., Holt J. T., Matrisian L. M. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science. 1988 Dec 9;242(4884):1424–1427. doi: 10.1126/science.2462278. [DOI] [PubMed] [Google Scholar]
  35. Kouzarides T., Ziff E. Behind the Fos and Jun leucine zipper. Cancer Cells. 1989 Nov;1(3):71–76. [PubMed] [Google Scholar]
  36. Lassar A. B., Thayer M. J., Overell R. W., Weintraub H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell. 1989 Aug 25;58(4):659–667. doi: 10.1016/0092-8674(89)90101-3. [DOI] [PubMed] [Google Scholar]
  37. Lavigueur A., Maltby V., Mock D., Rossant J., Pawson T., Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol. 1989 Sep;9(9):3982–3991. doi: 10.1128/mcb.9.9.3982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lee W., Mitchell P., Tjian R. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell. 1987 Jun 19;49(6):741–752. doi: 10.1016/0092-8674(87)90612-x. [DOI] [PubMed] [Google Scholar]
  39. Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature. 1991 Jun 6;351(6326):453–456. doi: 10.1038/351453a0. [DOI] [PubMed] [Google Scholar]
  40. Lian J. B., Stein G. S., Bortell R., Owen T. A. Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes. J Cell Biochem. 1991 Jan;45(1):9–14. doi: 10.1002/jcb.240450106. [DOI] [PubMed] [Google Scholar]
  41. Lucibello F. C., Lowag C., Neuberg M., Müller R. trans-repression of the mouse c-fos promoter: a novel mechanism of Fos-mediated trans-regulation. Cell. 1989 Dec 22;59(6):999–1007. doi: 10.1016/0092-8674(89)90756-3. [DOI] [PubMed] [Google Scholar]
  42. Majeska R. J., Rodan G. A. The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem. 1982 Apr 10;257(7):3362–3365. [PubMed] [Google Scholar]
  43. Masuda H., Miller C., Koeffler H. P., Battifora H., Cline M. J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716–7719. doi: 10.1073/pnas.84.21.7716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Miller A. D., Curran T., Verma I. M. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell. 1984 Jan;36(1):51–60. doi: 10.1016/0092-8674(84)90073-4. [DOI] [PubMed] [Google Scholar]
  45. Minghetti P. P., Norman A. W. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 1988 Dec;2(15):3043–3053. doi: 10.1096/fasebj.2.15.2847948. [DOI] [PubMed] [Google Scholar]
  46. Mitchell R. L., Henning-Chubb C., Huberman E., Verma I. M. c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell. 1986 May 23;45(4):497–504. doi: 10.1016/0092-8674(86)90281-3. [DOI] [PubMed] [Google Scholar]
  47. Morello D., Moore G., Salmon A. M., Yaniv M., Babinet C. Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice. EMBO J. 1986 Aug;5(8):1877–1883. doi: 10.1002/j.1460-2075.1986.tb04439.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Morgan J. I., Cohen D. R., Hempstead J. L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 1987 Jul 10;237(4811):192–197. doi: 10.1126/science.3037702. [DOI] [PubMed] [Google Scholar]
  49. Morrison N. A., Shine J., Fragonas J. C., Verkest V., McMenemy M. L., Eisman J. A. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science. 1989 Dec 1;246(4934):1158–1161. doi: 10.1126/science.2588000. [DOI] [PubMed] [Google Scholar]
  50. Müller R., Müller D., Guilbert L. Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J. 1984 Aug;3(8):1887–1890. doi: 10.1002/j.1460-2075.1984.tb02063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Müller R., Wagner E. F. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature. 1984 Oct 4;311(5985):438–442. doi: 10.1038/311438a0. [DOI] [PubMed] [Google Scholar]
  52. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989 Dec 7;342(6250):705–708. doi: 10.1038/342705a0. [DOI] [PubMed] [Google Scholar]
  53. Nijweide P. J., Burger E. H., Feyen J. H. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev. 1986 Oct;66(4):855–886. doi: 10.1152/physrev.1986.66.4.855. [DOI] [PubMed] [Google Scholar]
  54. Noda M., Vogel R. L., Craig A. M., Prahl J., DeLuca H. F., Denhardt D. T. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9995–9999. doi: 10.1073/pnas.87.24.9995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ofir R., Dwarki V. J., Rashid D., Verma I. M. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature. 1990 Nov 1;348(6296):80–82. doi: 10.1038/348080a0. [DOI] [PubMed] [Google Scholar]
  56. Ohta S., Yamamuro T., Lee K., Okumura H., Kasai R., Hiraki Y., Ikeda T., Iwasaki R., Kikuchi H., Konishi J. Fracture healing induces expression of the proto-oncogene c-fos in vivo. Possible involvement of the Fos protein in osteoblastic differentiation. FEBS Lett. 1991 Jun 17;284(1):42–45. doi: 10.1016/0014-5793(91)80757-t. [DOI] [PubMed] [Google Scholar]
  57. Ovitt C. E., Rüther U. The proto-oncogene c-fos: structure, expression, and functional aspects. Oxf Surv Eukaryot Genes. 1989;6:33–51. [PubMed] [Google Scholar]
  58. Owen T. A., Bortell R., Yocum S. A., Smock S. L., Zhang M., Abate C., Shalhoub V., Aronin N., Wright K. L., van Wijnen A. J. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9990–9994. doi: 10.1073/pnas.87.24.9990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Ozato K., Wan Y. J., Orrison B. M. Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2427–2431. doi: 10.1073/pnas.82.8.2427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Pelto-Huikko M., Schultz R., Koistinaho J., Hökfelt T. Immunocytochemical demonstration of c-fos protein in sertoli cells and germ cells in rat testis. Acta Physiol Scand. 1991 Feb;141(2):283–284. doi: 10.1111/j.1748-1716.1991.tb09080.x. [DOI] [PubMed] [Google Scholar]
  61. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991 Oct 17;353(6345):670–674. doi: 10.1038/353670a0. [DOI] [PubMed] [Google Scholar]
  62. Rahm M., Jin P., Sümegi J., Sejersen T. Elevated c-fos expression inhibits differentiation of L6 rat myoblasts. J Cell Physiol. 1989 May;139(2):237–244. doi: 10.1002/jcp.1041390204. [DOI] [PubMed] [Google Scholar]
  63. Ransone L. J., Verma I. M. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol. 1990;6:539–557. doi: 10.1146/annurev.cb.06.110190.002543. [DOI] [PubMed] [Google Scholar]
  64. Redemann-Fibi B., Schuermann M., Müller R. Stage and tissue-specific expression of fosB during mouse development. Differentiation. 1991 Feb;46(1):43–49. doi: 10.1111/j.1432-0436.1991.tb00864.x. [DOI] [PubMed] [Google Scholar]
  65. Ryseck R. P., Hirai S. I., Yaniv M., Bravo R. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature. 1988 Aug 11;334(6182):535–537. doi: 10.1038/334535a0. [DOI] [PubMed] [Google Scholar]
  66. Rüther U., Garber C., Komitowski D., Müller R., Wagner E. F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. 1987 Jan 29-Feb 4Nature. 325(6103):412–416. doi: 10.1038/325412a0. [DOI] [PubMed] [Google Scholar]
  67. Rüther U., Komitowski D., Schubert F. R., Wagner E. F. c-fos expression induces bone tumors in transgenic mice. Oncogene. 1989 Jul;4(7):861–865. [PubMed] [Google Scholar]
  68. Rüther U., Müller W., Sumida T., Tokuhisa T., Rajewsky K., Wagner E. F. c-fos expression interferes with thymus development in transgenic mice. Cell. 1988 Jun 17;53(6):847–856. doi: 10.1016/s0092-8674(88)90289-9. [DOI] [PubMed] [Google Scholar]
  69. Rüther U., Wagner E. F., Müller R. Analysis of the differentiation-promoting potential of inducible c-fos genes introduced into embryonal carcinoma cells. EMBO J. 1985 Jul;4(7):1775–1781. doi: 10.1002/j.1460-2075.1985.tb03850.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Rüther U., Wagner E. F. The specific consequences of c-fos expression in transgenic mice. Prog Nucleic Acid Res Mol Biol. 1989;36:235–245. doi: 10.1016/s0079-6603(08)60174-9. [DOI] [PubMed] [Google Scholar]
  71. Sandberg M., Vuorio T., Hirvonen H., Alitalo K., Vuorio E. Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development. 1988 Mar;102(3):461–470. doi: 10.1242/dev.102.3.461. [DOI] [PubMed] [Google Scholar]
  72. Sassone-Corsi P., Ransone L. J., Lamph W. W., Verma I. M. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature. 1988 Dec 15;336(6200):692–695. doi: 10.1038/336692a0. [DOI] [PubMed] [Google Scholar]
  73. Schmidt J., Livne E., Erfle V., Gössner W., Silbermann M. Morphology and in vivo growth characteristics of an atypical murine proliferative osseous lesion induced in vitro. Cancer Res. 1986 Jun;46(6):3090–3098. [PubMed] [Google Scholar]
  74. Schuermann M., Neuberg M., Hunter J. B., Jenuwein T., Ryseck R. P., Bravo R., Müller R. The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell. 1989 Feb 10;56(3):507–516. doi: 10.1016/0092-8674(89)90253-5. [DOI] [PubMed] [Google Scholar]
  75. Schön A., Michiels L., Janowski M., Merregaert J., Erfle V. Expression of protooncogenes in murine osteosarcomas. Int J Cancer. 1986 Jul 15;38(1):67–74. doi: 10.1002/ijc.2910380112. [DOI] [PubMed] [Google Scholar]
  76. Schönthal A., Herrlich P., Rahmsdorf H. J., Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell. 1988 Jul 29;54(3):325–334. doi: 10.1016/0092-8674(88)90195-x. [DOI] [PubMed] [Google Scholar]
  77. Schüle R., Umesono K., Mangelsdorf D. J., Bolado J., Pike J. W., Evans R. M. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell. 1990 May 4;61(3):497–504. doi: 10.1016/0092-8674(90)90531-i. [DOI] [PubMed] [Google Scholar]
  78. Senger D. R., Perruzzi C. A., Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res. 1989 Sep-Oct;9(5):1291–1299. [PubMed] [Google Scholar]
  79. Smeyne R. J., Schilling K., Robertson L., Luk D., Oberdick J., Curran T., Morgan J. I. fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron. 1992 Jan;8(1):13–23. doi: 10.1016/0896-6273(92)90105-m. [DOI] [PubMed] [Google Scholar]
  80. Spiess Y. H., Price P. A., Deftos J. L., Manolagas S. C. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. Endocrinology. 1986 Apr;118(4):1340–1346. doi: 10.1210/endo-118-4-1340. [DOI] [PubMed] [Google Scholar]
  81. Strauss P. G., Mitreiter K., Zitzelsberger H., Luz A., Schmidt J., Erfle V., Höfler H. Elevated p53 RNA expression correlates with incomplete osteogenic differentiation of radiation-induced murine osteosarcomas. Int J Cancer. 1992 Jan 21;50(2):252–258. doi: 10.1002/ijc.2910500215. [DOI] [PubMed] [Google Scholar]
  82. Strömstedt P. E., Poellinger L., Gustafsson J. A., Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol Cell Biol. 1991 Jun;11(6):3379–3383. doi: 10.1128/mcb.11.6.3379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell. 1985 Oct;42(3):889–902. doi: 10.1016/0092-8674(85)90285-5. [DOI] [PubMed] [Google Scholar]
  84. Turksen K., Aubin J. E. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol. 1991 Jul;114(2):373–384. doi: 10.1083/jcb.114.2.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Van Beveren C., van Straaten F., Curran T., Müller R., Verma I. M. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell. 1983 Apr;32(4):1241–1255. doi: 10.1016/0092-8674(83)90306-9. [DOI] [PubMed] [Google Scholar]
  86. Wang Z. Q., Grigoriadis A. E., Möhle-Steinlein U., Wagner E. F. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J. 1991 Sep;10(9):2437–2450. doi: 10.1002/j.1460-2075.1991.tb07783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Wang Z. Q., Grigoriadis A. E., Wagner E. F. Stable murine chondrogenic cell lines derived from c-fos-induced cartilage tumors. J Bone Miner Res. 1993 Jul;8(7):839–847. doi: 10.1002/jbmr.5650080710. [DOI] [PubMed] [Google Scholar]
  88. Wang Z. Q., Ovitt C., Grigoriadis A. E., Möhle-Steinlein U., Rüther U., Wagner E. F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992 Dec 24;360(6406):741–745. doi: 10.1038/360741a0. [DOI] [PubMed] [Google Scholar]
  89. Ward J. M., Young D. M. Histogenesis and Morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice. Cancer Res. 1976 Nov;36(11 Pt 1):3985–3992. [PubMed] [Google Scholar]
  90. Weinberg R. A. Tumor suppressor genes. Science. 1991 Nov 22;254(5035):1138–1146. doi: 10.1126/science.1659741. [DOI] [PubMed] [Google Scholar]
  91. Wilkinson D. G., Bhatt S., Ryseck R. P., Bravo R. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development. 1989 Jul;106(3):465–471. doi: 10.1242/dev.106.3.465. [DOI] [PubMed] [Google Scholar]
  92. Wu J. X., Carpenter P. M., Gresens C., Keh R., Niman H., Morris J. W., Mercola D. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene. 1990 Jul;5(7):989–1000. [PubMed] [Google Scholar]
  93. Yoon K., Buenaga R., Rodan G. A. Tissue specificity and developmental expression of rat osteopontin. Biochem Biophys Res Commun. 1987 Nov 13;148(3):1129–1136. doi: 10.1016/s0006-291x(87)80250-4. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES